Systemic inflammation as a risk factor for atherothrombosis

Rheumatology (Oxford). 2008 Jan;47(1):3-7. doi: 10.1093/rheumatology/kem202. Epub 2007 Aug 16.


Several chronic inflammatory disorders, such as systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA), and chronic infections that are associated with a chronic inflammatory state, such as human immunodeficiency virus (HIV) infection, are associated with an increased incidence of cardiovascular disease (CVD). Cardiovascular mortality is a major cause of death in patients with these disorders. Direct effects and indirect sequelae of systemic inflammation promote atherothrombotic vascular disease. Pathophysiological processes promoting atherogenesis can initiate years before the diagnosis of a chronic inflammatory disease is made, and since exposure to risk factors in this pre-clinical phase is widespread, early cardiovascular protection in these patients seems warranted.

Publication types

  • Review

MeSH terms

  • Arteriosclerosis / epidemiology*
  • Arteriosclerosis / etiology
  • Arteriosclerosis / physiopathology
  • Arthritis, Rheumatoid / complications
  • Arthritis, Rheumatoid / epidemiology*
  • Arthritis, Rheumatoid / physiopathology
  • Comorbidity
  • Humans
  • Inflammation / complications
  • Inflammation / epidemiology*
  • Inflammation / physiopathology
  • Lupus Erythematosus, Systemic / complications
  • Lupus Erythematosus, Systemic / epidemiology*
  • Lupus Erythematosus, Systemic / physiopathology
  • Risk Factors